Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Maria Bassanelli"'
Multimodality treatment of brain metastases from renal cell carcinoma in the era of targeted therapy
Autor:
Maria Bassanelli, Antonella Viterbo, Michela Roberto, Silvana Giacinti, Anita Staddon, Anna Maria Aschelter, Chiara D’Antonio, Paolo Marchetti
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 8 (2016)
In patients with renal cancer, brain metastasis is associated with poor survival and high morbidity. Poor life expectancy is often associated with widespread extracranial metastases. In such patients, a multidisciplinary approach is paramount. Brain
Externí odkaz:
https://doaj.org/article/1db127d274f3416e9672d6ed9030426a
Autor:
Michela Roberto, Maria Bassanelli, Elsa Iannicelli, Silvana Giacinti, Chiara D’Antonio, Anna Maria Aschelter, Paolo Marchetti
Publikováno v:
Case Reports in Oncological Medicine, Vol 2015 (2015)
Background. Renal cell carcinoma accounts for about 2-3% of all malignant tumors. The prevalence of brain metastases from RCC is less than 20% of cases. Traditionally, whole brain radiotherapy as well as the latest stereotactic radiosurgery improves
Externí odkaz:
https://doaj.org/article/82c004c9a2f94422b5ec8f5a13c0468e
Autor:
Matteo Santoni, Francesco Massari, Zin W. Myint, Roberto Iacovelli, Martin Pichler, Umberto Basso, Jindrich Kopecky, Jakub Kucharz, Sebastiano Buti, Alessia Salfi, Thomas Büttner, Ugo De Giorgi, Ravindran Kanesvaran, Ondřej Fiala, Enrique Grande, Paolo Andrea Zucali, Giuseppe Fornarini, Maria T Bourlon, Sarah Scagliarini, Javier Molina-Cerrillo, Gaetano Aurilio, Marc R Matrana, Renate Pichler, Carlo Cattrini, Tomas Büchler, Emmanuel Seront, Fabio Calabrò, Alvaro Pinto, Rossana Berardi, Anca Zgura, Giulia Mammone, Jawaher Ansari, Francesco Atzori, Rita Chiari, Roubini Zakopoulou, Orazio Caffo, Giuseppe Procopio, Maria Bassanelli, Ilaria Zampiva, Carlo Messina, Zsófia Küronya, Alessandra Mosca, Dipen Bhuva, Nuno Vau, Lorena Incorvaia, Sara Elena Rebuzzi, Giandomenico Roviello, Ignacio Ortego Zabalza, Alessandro Rizzo, Veronica Mollica, Ilaria Catalini, Fernando Sabino M. Monteiro, Rodolfo Montironi, Nicola Battelli, Mimma Rizzo, Camillo Porta
Background: Obesity has been associated with improved response to immunotherapy in cancer patients. We investigated the role of body mass index (BMI) in patients from the ARON-1 study (NCT05287464) treated by dual immuno-oncology agents (IO+IO) or a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12f357fc06502ee653e2380faa5136fd
https://hdl.handle.net/10447/587700
https://hdl.handle.net/10447/587700
Publikováno v:
Anticancer Research. 42:2241-2247
Immune checkpoint inhibitors (ICPi) targeting programmed cell death 1(PD-1)/programmed cell death ligand-1 (PD-L1) have revolutionized the treatment of patients with advanced non-small cell lung cancer (NSCLC). Despite impressive success, only a smal
Autor:
M. Reni, E. Giommoni, F. Bergamo, M. Milella, L. Cavanna, M.C. Di Marco, M. Spada, S. Cordio, G. Aprile, G.G. Cardellino, E. Maiello, I. Bernardini, M. Ghidini, S. Bozzarelli, M. Macchini, G. Orsi, I. De Simone, Er. Rulli, L. Porcu, V. Torri, C. Pinto, Michele Reni, Marina Macchini, Giulia Orsi, Umberto Peretti, Mariamaddalena Valente, Elisa Giommoni, Lorenzo Antonuzzo, Francesco Di Costanzo, Francesca Bergamo, Vittorina Zagonel, Sara Lonardi, Federica Buggin, Michele Milella, Silvia Palmerio, Luigi Cavanna, Camilla Di Nunzio, Maria Cristina Di Marco, Elisa Grassi, Massimiliano Spada, Marco Messina, Stefano Cordio, Francesco Avola, Giuseppe Aprile, Salvatore Pagano, Francesca Simionato, Giovanni Gerardo Cardellino, Federica Majer, Evaristo Maiello, Tiziana Pia Latiano, Cinzia Chiarazzo, Fabrizio Artioli, Giorgia Razzini, Antonella Pasqualini, Michele Ghidini, Elisa Binda, Silvia Lazzarelli, Silvia Bozzarelli, Simona Sala, Gabriele Luppi, Elisa Pettorelli, Andrea Spallanzani, Giovanni Vicario, Flavia Salmaso, Marco Basso, Nicola Silvestris, Sabina Del Curatolo, Fable Zustovich, Francesca Bongiovanni, Ciro Longobardi, Ilenia Sandi, Caterina Fontanella, Silvia Montelatici, Monica Giordano, Giovanna Luchena, Micol Gilardoni, Emiliano Tamburini, Britt Rudnas, Barbara Venturini, Barbara Merelli, Giorgia Negrini, Elio Maria Vici, Alessandra Marabese, Cristina Garetto, Paola Curcio, Saverio Cinieri, Margherita Cinefra, Pasqualinda Ferrara, Maurizio Cantore, Patrizia Morselli, Guglielmo Fumi, Agnese Isidori, Giovanni Ciccarese, Giovanni Luca Paolo Frassineti, Flavia Pagan, Vanja Vaccaro, Chiara Spoto, Marianna Ferrara, Carlo Garufi, Marta Caporale, Enrico Vasile, Francesca Salani, Elisa Barone, Rossana Berardi, Azzurra Onofri, Zelmira Ballatore, Alessandra Lucarelli, Alessandra Barucca, Amedeo Pancotti, Teresa Scipioni, Katia Bencardino, Giovanna Marrapese, Laura Idotta, Fausto Petrelli, Veronica Lonati, Anna Ceribelli, Angelo Giuli, Cristina Zannori, Maria Bassanelli, Andrea Mambrini, Laura Ginocchi, Massimo Orlandi, Luigi Celio, Monica Niger, Lavinia Biamonte, Stefano Tamberi, Alessandra Piancastelli, Giorgio Papiani, Irene Valli, Paolo Allione, Maria Giovanna Boe, Mario Scartozzi, Eleonora Lai, Annagrazia Pireddu, Pina Ziranu, Laura Demurtas, Marco Puzzoni, Stefano Mariani, Andrea Pretta, Nicole Liscia, Clementina Savastano, Valentina Malaspina, Giuseppe Tonini, Teresa Grassani, Barbara Barco, Tagliaferri Pierosandro, Domenico Ciliberto, Antonella Ierardi, Natale Daniele Calandruccio, Vincenzo Minotti, Roberta Matocci, Valter Torri, Luca Porcu, Erica Rulli, Irene De Simone, Luciano Carlucci, Eliana Rulli, Davide Poli, Paola Tonto, Francesca Scellato, Carmine Pinto
Background: Information about the adherence to scientific societies guidelines in the ‘real-world’ therapeutic management of oncological patients are lacking. This multicenter, prospective survey was aimed to improve the knowledge relative to 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f827f8705c922ff764aa383826811530
https://hdl.handle.net/11585/919206
https://hdl.handle.net/11585/919206
Autor:
Matteo Santoni, Javier Molina-Cerrillo, Zin W. Myint, Francesco Massari, Tomas Buchler, Sebastiano Buti, Marc R. Matrana, Ugo De Giorgi, Mimma Rizzo, Ignacio Ortego Zabalza, Luca Galli, Paolo Andrea Zucali, Gaetano Aurilio, Lorena Incorvaia, Maria Bassanelli, Giulia Mammone, Alessia Salfi, Luca Isella, Veronica Mollica, Enrique Grande, Camillo Porta, Nicola Battelli
Publikováno v:
Targeted oncology. 17(5)
Background Drug-drug interactions are a major concern in oncology and may potentially affect the outcome of patients with cancer. Objective In this study, we aimed to determine whether the concomitant use of statins, metformin, or proton pump inhibit
Autor:
Michele Milella, Francesco Cognetti, Michela Roberto, Fabiana Letizia Cecere, Biagio Ricciuti, Viola Barucca, Maria Bassanelli, Paolo Marchetti, Silvana Giacinti, Alain Gelibter, Mario Santarelli, Enzo Maria Ruggeri, Anna Ceribelli, Enrico Cortesi, Rita Chiari, Diana Giannarelli
Background: The combination of radiotherapy (RT) and programmed death 1 inhibitors seems to increase antitumor immune responses. Objective: To assess the outcome and the role of the best combination sequence, i.e. immunotherapy given before, during,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e39a5f5f3cd3b0bd0d890188e6007d6
https://hdl.handle.net/11573/1676730
https://hdl.handle.net/11573/1676730
Autor:
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Giuseppe Fotia, Mariella Sorarù, Maria Bassanelli, Brigida Anna Maiorano, Francesco Grillone, Luca Galli, Roberto Filippi, Martina Fanelli, Michele Dionese, Michele Maffezzoli, Bruno Vincenzi, Giuseppe Procopio, Elena Verzoni
Publikováno v:
Journal of Clinical Oncology. 41:638-638
638 Background: Peritoneal metastases (PM) have been reported in approximately 1% of patients (pts) with metastatic Renal Cell Carcinoma (mRCC). Outcome data are limited due to the rarity of this metastatic site. Therefore, the aim of our study is to
Autor:
Maria Bassanelli, Marina Borro, Michela Roberto, Diana Giannarelli, Silvana Giacinti, Simona Di Martino, Anna Ceribelli, Andrea Russo, Annamaria Aschelter, Stefania Scarpino, Andrea Montori, Edoardo Pescarmona, Silverio Tomao, Maurizio Simmaco, Francesco Cognetti, Michele Milella, Paolo Marchetti
Publikováno v:
Cancers
Cancers, Vol 14, Iss 178, p 178 (2022)
Cancers; Volume 14; Issue 1; Pages: 178
Cancers, Vol 14, Iss 178, p 178 (2022)
Cancers; Volume 14; Issue 1; Pages: 178
Simple Summary Our analysis of a 17-gene expression signature resulted in being significantly different among patients with clear cell renal cancer cell (ccRCC) who reported a recurrence-free survival (RFS) >5 years and patients with a RFS < 1 year.
Autor:
Mimma Rizzo, Alessandra Bearz, Lucia Fratino, Paola Ermacora, Camillo Porta, Maria Bassanelli, Giuseppe Fornarini, Giuseppe Procopio, Elena Verzoni, Davide Bimbatti, Francesco Massari, Umberto Basso, Michele Milella
Publikováno v:
Oncology. 99(12)
Introduction: Tivozanib is a potent and selective tyrosine kinase inhibitor of vascular endothelial growth factor receptor 1 (VEGFR-1), VEGFR-2, and VEGFR-3, recently approved in Europe for the first-line treatment of metastatic renal cell carcinoma